The product of the c-myc proto-oncogene is an important regulator of c
ell proliferation and apoptosis in murine fibroblasts. Addition of the
tumor promoter, phorbol myristate acetate (PMA), prevents apoptotic c
ell death induced by low serum concentrations in NIH3T3 cells that con
stitutively express and are transformed by v-myc. The protective effec
t of PMA allowed us to analyse the ability of normal c-Myc and Myc del
etion mutants to induce serum starved, untransformed NIH3T3 cells to e
nter S phase. By microinjecting these quiescent cells with wild type a
nd mutant human c-myc plasmids, we showed that full length c-myc is ab
le to induce S phase entry in presence of PMA, but that c-Myc mutants
that delete amino acids Delta 7/91, Delta 41/53, Delta 56/103, Delta 1
06/143, Delta 265/317 and Delta 414/433 are totally inactive. c-Myc di
d not shorten the period before entry into S phase, since Myc overexpr
essing cells entered S phase with the same kinetics as control cells w
hen both were stimulated with 20% fetal calf serum (FCS). However, c-M
yc overexpression did increase the percentage of cells entering S phas
e when these cells were stimulated with 2% fetal calf serum. Interesti
ngly, this ability to enhance stimulation by a suboptimal concentratio
n of FCS was retained to a significant degree by Myc mutants that dele
te amino acids Delta 41/53, Delta 56/103 or Delta 265/317. Finally, My
c mutants that delete Delta 106/143 or Delta 414/433 exerted a dominan
t negative effect on S phase entry both in quiescent cells stimulated
with 2% FCS and in unsynchronized, cycling cells.